ECOLAB INC. ECL
General Development of Business.
Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31. International subsidiaries are included in the consolidated financial statements on the basis of their U.S. GAAP (accounting principles generally accepted in the United States of America) November 30 fiscal year ends to facilitate the timely inclusion of such entities in our consolidated financial reporting.
Narrative Description of Business.
A trusted partner for millions of customers, we are a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, we have advanced innovation by integrating science-based solutions, data-driven insights, AI-technology and world-class service. This unique combination enables us to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, we have $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. We help protect one-third of the world's food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Our comprehensive approach protects what's vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.08B | $15.74B | $15.32B | $14.19B | $12.73B | $11.79B | $12.56B | $12.22B | $11.53B | $13.15B |
| Cost of revenue | $8.93B | $8.90B | $9.15B | $8.83B | $7.62B | $6.91B | $7.05B | $6.88B | $6.41B | $7.53B |
| Gross profit | $7.15B | $6.84B | $6.17B | $5.36B | $5.12B | $4.88B | $5.52B | $5.35B | $5.12B | $5.62B |
| R&D | $202.0M | $207.0M | $192.0M | $190.0M | $186.0M | $185.0M | $190.0M | $193.0M | $177.0M | $189.0M |
| SG&A | $4.26B | $4.23B | $4.06B | $3.65B | $3.42B | $3.31B | $3.55B | $3.51B | $3.36B | $3.71B |
| Operating income | $2.74B | $2.80B | $1.99B | $1.56B | $1.60B | $1.40B | $1.85B | $1.73B | $1.75B | $1.87B |
| Interest expense | $306.2M | $340.3M | $348.9M | $252.1M | $230.6M | $304.8M | $214.4M | $235.5M | $272.2M | $285.4M |
| Pre-tax income | $2.55B | $2.57B | $1.76B | $1.34B | $1.41B | $1.16B | $1.73B | $1.59B | $1.56B | $1.65B |
| Income tax | $454.6M | $439.3M | $362.5M | $234.5M | $270.2M | $176.6M | $288.6M | $321.2M | $189.8M | $402.9M |
| Net income | $2.08B | $2.11B | $1.37B | $1.09B | $1.13B | -$1.19B | $1.58B | $1.44B | $1.52B | $1.25B |
| EPS, basic | 7.33 | 7.43 | 4.82 | 3.83 | 3.95 | -4.20 | 5.41 | 4.95 | 5.20 | 4.20 |
| EPS, diluted | 7.28 | 7.37 | 4.79 | 3.81 | 3.91 | -4.15 | 5.33 | 4.88 | 5.12 | 4.14 |
| Shares, diluted (wtd. avg.) | $285.2M | $286.6M | $286.5M | $286.6M | $289.1M | $290.3M | $292.5M | $292.8M | $294.0M | $296.7M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $646.2M | $1.26B | $919.5M | $598.6M | $359.9M | $1.26B | $118.8M | $243.2M | $163.3M | $380.4M |
| Receivables | $3.25B | $2.87B | $2.83B | $2.70B | $2.48B | $2.27B | $2.38B | $2.66B | $2.57B | $2.34B |
| Inventory | $1.49B | $1.46B | $1.50B | $1.79B | $1.49B | $1.29B | $1.08B | $1.55B | $1.45B | $1.32B |
| Total current assets | $5.96B | $6.03B | $5.64B | $5.49B | $4.69B | $5.12B | $4.83B | $4.68B | $4.59B | $4.28B |
| Property, plant and equipment | $4.28B | $3.75B | $3.47B | $3.29B | $3.29B | $3.12B | $3.23B | $3.84B | $3.71B | $3.37B |
| Goodwill | $9.23B | $7.91B | $8.15B | $8.01B | $8.06B | $6.01B | $5.57B | $5.39B | $7.17B | $6.38B |
| Other intangibles | $3.69B | $3.31B | $3.49B | $3.68B | $4.22B | $2.98B | $2.93B | $3.80B | $4.02B | $3.82B |
| Total assets | $24.70B | $22.39B | $21.85B | $21.46B | $21.21B | $18.13B | $20.87B | $20.07B | $19.96B | $18.33B |
| Accounts payable | $2.07B | $1.81B | $1.57B | $1.73B | $1.38B | $1.16B | $1.08B | $1.26B | $1.18B | $983.2M |
| Short-term debt | $870.4M | $615.7M | $630.4M | $505.1M | $411.0M | $17.3M | $380.5M | $743.6M | $564.4M | $541.3M |
| Total current liabilities | $5.53B | $4.79B | $4.35B | $4.21B | $3.55B | $2.93B | $3.63B | $3.69B | $3.48B | $3.02B |
| Total liabilities | $14.89B | $13.60B | $13.77B | $14.21B | $13.95B | $11.92B | $12.14B | $12.02B | $12.31B | $11.36B |
| Retained earnings | $12.83B | $11.52B | $10.08B | $9.32B | $8.81B | $8.24B | $9.99B | $8.91B | $8.01B | $6.97B |
| Total equity | $9.77B | $8.76B | $8.07B | $7.26B | $7.25B | $6.20B | $8.73B | $8.05B | $7.65B | $6.94B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.95B | $2.81B | $2.41B | $1.79B | $2.06B | $1.86B | $2.42B | $2.28B | $2.09B | $1.94B |
| Depreciation and amortisation | $672.6M | $634.9M | $616.7M | $618.5M | $604.4M | $594.3M | $569.1M | $535.9M | $500.1M | $561.0M |
| Stock-based compensation | $136.6M | $134.8M | $95.1M | $87.8M | $89.5M | $82.1M | $84.0M | $88.0M | $85.5M | $85.7M |
| Capital expenditure | $1.05B | $994.5M | $774.8M | $712.8M | $643.0M | $489.0M | $731.3M | $778.7M | $787.4M | $756.8M |
| Investing cash flow | -$2.71B | -$433.8M | -$990.5M | -$716.8M | -$4.58B | -$414.5M | -$1.20B | -$1.03B | -$1.73B | -$773.6M |
| Financing cash flow | -$853.3M | -$2.02B | -$1.05B | -$837.3M | $1.60B | -$341.8M | -$1.35B | -$1.17B | -$522.7M | -$868.2M |
| Dividends paid | $753.6M | $664.3M | $617.3M | $602.8M | $566.4M | $560.8M | $552.9M | $494.8M | $443.4M | $427.5M |
| Buybacks | $783.8M | $986.5M | $13.7M | $518.2M | $106.6M | $146.2M | $353.7M | $562.4M | $600.3M | $739.6M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-018357.
Others in SIC 2840
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $340.39B | 22.1x | 3.3% |
| CHD | CHURCH & DWIGHT CO INC /DE/ | $23.38B | 32.6x | 1.6% |
| SCL | STEPAN CO | $1.44B | 30.9x | 7.0% |
| UL | UNILEVER PLC | — | — | — |
| WNW | Meiwu Technology Co Ltd | — | — | 4,368.0% |
| BYAH | Park Ha Biological Technology Co., Ltd. | — | — | 6.0% |